VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 46 filers reported holding VERRICA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $635 | -22.3% | 163,550 | +15.5% | 0.00% | -20.0% |
| Q2 2023 | $817 | +8.9% | 141,550 | +22.7% | 0.01% | 0.0% |
| Q1 2023 | $750 | +174.7% | 115,350 | +16.1% | 0.01% | +150.0% |
| Q4 2022 | $273 | -99.9% | 99,350 | +10.5% | 0.00% | 0.0% |
| Q3 2022 | $263,000 | +213.1% | 89,950 | +104.9% | 0.00% | +100.0% |
| Q2 2022 | $84,000 | -82.9% | 43,900 | -27.4% | 0.00% | -66.7% |
| Q1 2022 | $491,000 | +5.4% | 60,500 | +18.9% | 0.00% | 0.0% |
| Q4 2021 | $466,000 | -16.9% | 50,875 | +13.4% | 0.00% | -25.0% |
| Q3 2021 | $561,000 | +43.8% | 44,875 | +30.2% | 0.00% | +33.3% |
| Q2 2021 | $390,000 | +22.3% | 34,475 | +63.6% | 0.00% | 0.0% |
| Q1 2021 | $319,000 | +4.2% | 21,075 | -20.7% | 0.00% | 0.0% |
| Q4 2020 | $306,000 | +243.8% | 26,575 | +131.1% | 0.00% | +200.0% |
| Q3 2020 | $89,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 108,794 | $1,252,000 | 0.47% |
| Perceptive Advisors | 3,410,412 | $39,254,000 | 0.42% |
| KNOTT DAVID M | 76,585 | $881,000 | 0.40% |
| Fosun International Ltd | 324,061 | $3,730,000 | 0.24% |
| Orbimed Advisors | 1,479,733 | $17,032,000 | 0.15% |
| SteelPeak Wealth, LLC | 132,961 | $1,530,000 | 0.14% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 665,511 | $7,660,000 | 0.13% |
| Capital Investment Advisory Services, LLC | 15,125 | $174,000 | 0.03% |
| BECK MACK & OLIVER LLC | 10,000 | $115,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 335,318 | $3,860,000 | 0.00% |